INMED PHARMACEUTICALS INC. Proceeds from Issuance of Warrants
INMED PHARMACEUTICALS INC. (INM) reported Proceeds from Issuance of Warrants of $231.68 thousand for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. proceeds from issuance of warrants for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- INMED PHARMACEUTICALS INC. proceeds from issuance of warrants for the quarter ending 2025-06-30 was $3.77M.
- INMED PHARMACEUTICALS INC. proceeds from issuance of warrants for the quarter ending 2025-03-31 was $2.94M.
- INMED PHARMACEUTICALS INC. proceeds from issuance of warrants for the quarter ending 2024-12-31 was $396.15K.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants as first filed | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $231.68K S-4/A · filed 2026-09-09 | ||||||
| 2026-03-31 | $231.68K S-4 · filed 2026-07-02 | |||||||
| 2025-06-30 | $3.77M derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $6.70M derived: sum of 2 quarters · filed 2026-09-09 | $7.10M derived: sum of 3 quarters · filed 2026-09-09 | $8.13M S-4/A · filed 2026-09-09 | $5.02M 10-K · filed 2025-09-23 | |||
| 2025-03-31 | $2.94M derived: S-4 9 month − 10-Q 6 month · filed 2026-07-02 | $3.33M derived: sum of 2 quarters · filed 2026-07-02 | $4.36M S-4 · filed 2026-07-02 | |||||
| 2024-12-31 | $396.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11 | $1.43M 10-Q · filed 2026-02-11 | ||||||
| 2024-09-30 | $1.03M 10-Q · filed 2025-11-06 | |||||||
| 2024-06-30 | $5.22M S-4 · filed 2026-07-02 | $3.50M 10-K · filed 2024-09-30 | ||||||
| 2023-12-31 | $3.50M 10-Q · filed 2024-02-13 | |||||||
| 2022-06-06 | $1.50M 10-K · filed 2023-09-29 | $3.50M 10-K · filed 2022-09-23 | ||||||
| 2021-09-13 | $6.00M 10-Q · filed 2022-11-14 | |||||||
| 2021-07-02 | $12.00M 10-K · filed 2022-09-23 | $12.00M 10-Q · filed 2022-05-13 | ||||||
| 2021-02-12 | $4.46M 10-K · filed 2021-09-24 | |||||||
| 2020-11-16 | $8.01M 10-K · filed 2021-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |